Andrew A. Hindman
Education: B.A. from Wesleyan University graduating Phi Beta Kappa, and executive MBA from Columbia University and the University of California Berkeley, Haas School of Business.
Main occupation: Chief Business Development Officer and Head, Financial Planning and Analysis & Investor Relations of Acorda Therapeutics, Inc.
Board membership began: Board member since December 2016
Employment history: Acorda’s Chief Business Development Officer since May 2014; prior to that, President, Chief Executive Officer and member of the Board of Tobira Therapeutics. Previously held senior corporate development and commercial operating positions at Nodality, Onyx Pharmaceuticals and Gilead Sciences.
Key positions of trust: Leadership team of Acorda Therapeutics, Inc.
Assessment of independence: Independent of the company, dependent of significant shareholder